Evexia Lifecare Ltd Stock Price Today (NSE: EVEXIA)
Fundamental Score
Evexia Lifecare Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Evexia Lifecare Ltd share price today is ₹0.84, up +0.00% on NSE/BSE as of 18 March 2026. Evexia Lifecare Ltd (EVEXIA) is a Small-cap company in the Trading - Chemicals sector with a market capitalisation of ₹332.28 (Cr). The 52-week high for EVEXIA share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 232.37x, EVEXIA is currently trading above its industry average P/E of 65.53x. The company has a Return on Equity (ROE) of 0.32% and a debt-to-equity ratio of 2.16.
Evexia Lifecare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Evexia Lifecare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Evexia Lifecare Share Price: A Conservative Value Investor's Perspective
Within the volatile world of chemical trading, where fortunes can swing dramatically based on raw material costs and global demand, the Evexia Lifecare share price currently sits at ₹1.65. As a conservative value investor focused on capital preservation, a deep dive into the financials is crucial before considering any potential investment. This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, designed to assess the intrinsic value and risk associated with Evexia Lifecare Ltd.
The reported Price-to-Earnings (PE) ratio of 232.37 immediately raises a red flag. Such a high multiple suggests that the market has exceedingly optimistic expectations for future earnings growth. Whether the company can deliver, and sustain, such extraordinary growth remains to be seen. We believe it would require detailed analysis of the projected contracts, margins, and competition to justify this PE.
A more concerning metric is Evexia Lifecare's Return on Capital Employed (ROCE) of a mere 0.3%. ROCE measures how efficiently a company generates profits from its capital. This extremely low figure indicates very poor capital allocation and suggests that the company struggles to create value for its shareholders. This low ROCE severely limits any potential economic moat, as competitors can easily replicate (or even surpass) this level of return, hindering Evexia's ability to sustain pricing power or achieve above-average profitability.
Furthermore, it's essential to compare Evexia Lifecare with its sector peers. While a direct comparison is difficult without granular data on management strategy and execution, companies like
Yash Chemex Ltd often demonstrate better operating efficiencies and strategic decision-making which translates into far better ROCE values than Evexia. Assessing management quality is crucial. Any potential investment requires a more detailed study of all aspects of the business. Observations suggest a need for significant improvements in operational efficiencies and capital allocation strategies to justify a positive outlook on the Evexia Lifecare share price.Disclaimer: This analysis is for informational purposes only and should not be construed as investment advice. Past performance is not indicative of future results.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Evexia Lifecare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EVEXIA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Interest Coverage (5.69x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
12 factors identified
Below-Average Return on Equity (0.32%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.30%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-15.09%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 232.37x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-60.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Growth History (1.97% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-38.44% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-23.15% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Elevated Debt Levels (D/E: 2.16)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Low Promoter Commitment (3.36%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 0.56%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Evexia Lifecare Ltd Financial Statements
Comprehensive financial data for Evexia Lifecare Ltd including income statement, balance sheet and cash flow
About EVEXIA (Evexia Lifecare Ltd)
Evexia Lifecare Ltd (EVEXIA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Trading - Chemicals sector with a current market capitalisation of ₹332.28 (Cr). Evexia Lifecare Ltd has delivered a Return on Equity (ROE) of 0.32% and a ROCE of 0.30%. The debt-to-equity ratio stands at 2.16, reflecting the company's capital structure. Investors tracking EVEXIA share price can monitor key metrics including P/E ratio, promoter holding of 3.36%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
EVEXIA Share Price: Frequently Asked Questions
What is the current share price of Evexia Lifecare Ltd (EVEXIA)?
As of 18 Mar 2026, 10:14 am IST, Evexia Lifecare Ltd share price is ₹0.84. The EVEXIA stock has a market capitalisation of ₹332.28 (Cr) on NSE/BSE.
Is EVEXIA share price Overvalued or Undervalued?
EVEXIA share price is currently trading at a P/E ratio of 232.37x, compared to the industry average of 65.53x. Based on this relative valuation, the Evexia Lifecare Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of EVEXIA share price?
The 52-week high of EVEXIA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Evexia Lifecare Ltd share price?
Key factors influencing EVEXIA share price include quarterly earnings growth (Sales Growth: -3.67%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Evexia Lifecare Ltd a good stock for long-term investment?
Evexia Lifecare Ltd shows a 5-year Profit Growth of -23.15% and an ROE of 0.32%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 2.16 before investing in EVEXIA shares.
How does Evexia Lifecare Ltd compare with its industry peers?
Evexia Lifecare Ltd competes with major peers in the Trading - Chemicals. Investors should compare EVEXIA share price P/E of 232.37x and ROE of 0.32% against the industry averages to determine competitive standing.
What is the P/E ratio of EVEXIA and what does it mean?
EVEXIA share price has a P/E ratio of 232.37x compared to the industry average of 65.53x. Investors pay ₹232 for every ₹1 of annual earnings.
How is EVEXIA performing according to Bull Run's analysis?
EVEXIA has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does EVEXIA belong to?
EVEXIA operates in the Trading - Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Evexia Lifecare Ltd share price.
What is Return on Equity (ROE) and why is it important for EVEXIA?
EVEXIA has an ROE of 0.32%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Evexia Lifecare Ltd generates profits from shareholders capital.
How is EVEXIA debt-to-equity ratio and what does it indicate?
EVEXIA has a debt-to-equity ratio of 2.16, which indicates high leverage that increases financial risk.
What is EVEXIA dividend yield and is it a good dividend stock?
EVEXIA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Evexia Lifecare Ltd shares.
How has EVEXIA share price grown over the past 5 years?
EVEXIA has achieved 5-year growth rates of: Sales Growth 1.97%, Profit Growth -23.15%, and EPS Growth -38.44%.
What is the promoter holding in EVEXIA and why does it matter?
Promoters hold 3.36% of EVEXIA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Evexia Lifecare Ltd.
What is EVEXIA market capitalisation category?
EVEXIA has a market capitalisation of ₹332 crores, placing it in the Small-cap category.
How volatile is EVEXIA stock?
EVEXIA has a beta of N/A. A beta > 1 suggests the Evexia Lifecare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is EVEXIA operating profit margin trend?
EVEXIA has a 5-year average Operating Profit Margin (OPM) of -15.09%, indicating the company's operational efficiency.
How is EVEXIA quarterly performance?
Recent quarterly performance shows Evexia Lifecare Ltd YoY Sales Growth of -3.67% and YoY Profit Growth of -60.64%.
What is the institutional holding pattern in EVEXIA?
EVEXIA has FII holding of 0.47% and DII holding of 0.09%. Significant institutional holding often suggests professional confidence in the Evexia Lifecare Ltd stock.